Home/Filings/4/0001127602-23-028980
4//SEC Filing

Peters Stanley W III 4

Accession 0001127602-23-028980

CIK 0000816956other

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 12:12 PM ET

Size

8.5 KB

Accession

0001127602-23-028980

Insider Transaction Report

Form 4
Period: 2023-12-04
Peters Stanley W III
VP GM General Surgery
Transactions
  • Exercise/Conversion

    Common Stock

    2023-12-04$41.93/sh+2,300$96,4392,363 total
  • Exercise/Conversion

    Options To Purchase Common Stock

    2023-12-042,3004,000 total
    Exercise: $41.93Exp: 2027-03-01Common Stock (2,300 underlying)
  • Sale

    Common Stock

    2023-12-04$109.93/sh2,300$252,83363 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.91 to $109.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  • [F2]The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Issuer

CONMED Corp

CIK 0000816956

Entity typeother

Related Parties

1
  • filerCIK 0001635365

Filing Metadata

Form type
4
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 12:12 PM ET
Size
8.5 KB